bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Sees Large Drop in Short Interest

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) was the target of a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 800 shares, a decline of 50.0% from the March 31st total of 1,600 shares. Based on an average daily trading volume, of 3,200 shares, the short-interest ratio is presently 0.3 days.

bioAffinity Technologies Trading Down 26.2 %

Shares of BIAFW stock traded down $0.16 during trading on Friday, hitting $0.45. The company had a trading volume of 331 shares, compared to its average volume of 4,360. The stock’s 50-day moving average price is $0.48 and its 200 day moving average price is $0.23. bioAffinity Technologies has a one year low of $0.05 and a one year high of $0.90.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.